Correlation Between Lumos Pharma and Transgene
Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and Transgene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and Transgene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lumos Pharma and Transgene SA, you can compare the effects of market volatilities on Lumos Pharma and Transgene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of Transgene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and Transgene.
Diversification Opportunities for Lumos Pharma and Transgene
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Lumos and Transgene is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and Transgene SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transgene SA and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with Transgene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transgene SA has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and Transgene go up and down completely randomly.
Pair Corralation between Lumos Pharma and Transgene
If you would invest 159.00 in Transgene SA on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Transgene SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lumos Pharma vs. Transgene SA
Performance |
Timeline |
Lumos Pharma |
Transgene SA |
Lumos Pharma and Transgene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lumos Pharma and Transgene
The main advantage of trading using opposite Lumos Pharma and Transgene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, Transgene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transgene will offset losses from the drop in Transgene's long position.Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Transgene vs. Here Media | Transgene vs. Employers Holdings | Transgene vs. Stagwell | Transgene vs. Sun Life Financial |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |